These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17266466)

  • 1. Skeletal bone diseases impact the periodontium: a review of bisphosphonate therapy.
    Palomo L; Liu J; Bissada NF
    Expert Opin Pharmacother; 2007 Feb; 8(3):309-15. PubMed ID: 17266466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is long-term bisphosphonate therapy associated with benefits to the periodontium in postmenopausal women?
    Palomo L; Buencamino-Francisco MC; Carey JJ; Sivanandy M; Thacker H
    Menopause; 2011 Feb; 18(2):164-70. PubMed ID: 20838348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
    Grewal VS; Fayans EP
    Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of bisphosphonates for periodontitis].
    Shinoda H; Takeyama S
    Clin Calcium; 2006 Feb; 16(2):341- 47. PubMed ID: 16465039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy insight: the risks and benefits of bisphosphonates for the treatment of tumor-induced bone disease.
    Dunstan CR; Felsenberg D; Seibel MJ
    Nat Clin Pract Oncol; 2007 Jan; 4(1):42-55. PubMed ID: 17183355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment.
    Ficarra G; Beninati F; Rubino I; Vannucchi A; Longo G; Tonelli P; Pini Prato G
    J Clin Periodontol; 2005 Nov; 32(11):1123-8. PubMed ID: 16212571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates.
    Farrugia MC; Summerlin DJ; Krowiak E; Huntley T; Freeman S; Borrowdale R; Tomich C
    Laryngoscope; 2006 Jan; 116(1):115-20. PubMed ID: 16481822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonate therapeutics in bone disease: the hard and soft data on osteoclast inhibition.
    Drake MT; Cremers SC
    Mol Interv; 2010 Jun; 10(3):141-52. PubMed ID: 20539033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates and osteonecrosis of the jaws: science and rationale.
    Gutta R; Louis PJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):186-93. PubMed ID: 17448709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonate therapy for bone loss in patients with osteoporosis and periodontal disease: clinical perspectives and review of the literature.
    Palomo L; Bissada N; Liu J
    Quintessence Int; 2006 Feb; 37(2):103-7. PubMed ID: 16475371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Osteonecrosis of the jaws by long term therapy with bisphosphonates].
    Piesold JU; Al-Nawas B; Grötz KA
    Mund Kiefer Gesichtschir; 2006 Sep; 10(5):287-300. PubMed ID: 16960697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bisphosphonates: indications in bone diseases other than osteoporosis].
    Abdelmoula LC; Ben M'barek R; Ben Hadj Yahia C; Tekaya R; Testouri N; Chaabouni L; Zouari R
    Tunis Med; 2011 Jun; 89(6):511-6. PubMed ID: 21681711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of osteoporosis and its treatment on oral health.
    Anil S; Preethanath RS; AlMoharib HS; Kamath KP; Anand PS
    Am J Med Sci; 2013 Nov; 346(5):396-401. PubMed ID: 23588259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complication related to bisphosphonate therapy: osteonecrosis of the jaw.
    Lee J
    J Infus Nurs; 2009; 32(6):330-5. PubMed ID: 19918142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis.
    Rizzoli R; Burlet N; Cahall D; Delmas PD; Eriksen EF; Felsenberg D; Grbic J; Jontell M; Landesberg R; Laslop A; Wollenhaupt M; Papapoulos S; Sezer O; Sprafka M; Reginster JY
    Bone; 2008 May; 42(5):841-7. PubMed ID: 18314405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.
    Marx RE; Sawatari Y; Fortin M; Broumand V
    J Oral Maxillofac Surg; 2005 Nov; 63(11):1567-75. PubMed ID: 16243172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals.
    Magopoulos C; Karakinaris G; Telioudis Z; Vahtsevanos K; Dimitrakopoulos I; Antoniadis K; Delaroudis S
    Am J Otolaryngol; 2007; 28(3):158-63. PubMed ID: 17499130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bisphosphonate treatment of osteoporosis and other skeletal diseases].
    Syversen U; Halse JI
    Tidsskr Nor Laegeforen; 2011 Feb; 131(3):244-7. PubMed ID: 21304573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteonecrosis of the jaws in patients with a history of receiving bisphosphonate therapy: strategies for prevention and early recognition.
    Melo MD; Obeid G
    J Am Dent Assoc; 2005 Dec; 136(12):1675-81. PubMed ID: 16383049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative use of bisphosphonate therapy for rheumatic disease.
    Le Goff B; Berthelot JM; Maugars Y; Romas E
    Curr Pharm Des; 2010; 16(27):3045-52. PubMed ID: 20722620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.